Fasltm2.1Bksa
Targeted Allele Detail
|
Symbol: |
Fasltm2.1Bksa |
Name: |
Fas ligand; targeted mutation 2.1, Bruce R Ksander |
MGI ID: |
MGI:5006688 |
Synonyms: |
FasLdeltaCS |
Gene: |
Fasl Location: Chr1:161608260-161616064 bp, - strand Genetic Position: Chr1, 69.95 cM
|
Alliance: |
Fasltm2.1Bksa page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:171440
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129
|
|
Allele Type: |
|
Targeted |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: Nucleotide substitution within exon 2 resulted in the amino acid substitution of threonine for serine at position 124 (S124T), phenylalanine for leucine at position 125 (L125F), arginine for lysine at position 127 (L127R), and glutamine for asparagine at position 128 (N128Q). These mutations prevent cleavage of the protein to produce the soluble form. The floxed neo cassette used for selection was removed by cre-mediated recombination.
(J:171440)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Fasl Mutation: |
37 strains or lines available
|
|
Original: |
J:171440 Gregory MS, et al., Opposing roles for membrane bound and soluble fas ligand in glaucoma-associated retinal ganglion cell death. PLoS One. 2011;6(3):e17659 |
All: |
2 reference(s) |
|